Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
General FTC sues Hims & Hers, alleging it shared people’s health data with Meta and SnapBy Healthcare Propulsion StaffJuly 29, 20260 The Federal Trade Commission sued Hims & Hers on Wednesday, alleging the telehealth platform shared customers’ health information with third-party…
